Pub Date : 2025-03-31DOI: 10.31053/1853.0605.v82.n1.44359
Maria Teresa Politi, Gustavo Javier Daquarti, Damián Néstor Spagnuolo, Raúl Ferreyra, Mirta Diez, Guillermo Bortman
Introduction: Patients hospitalized for heart failure with preserved ejection fraction (HFpEF) have a higher prevalence of anemia than those hospitalized for heart failure with reduced ejection fraction (HFpEF). However, it is unknown if this relationship is maintained in patients with chronic kidney disease, forming cardiorenal syndrome type IV.
Methods: Cross-sectional, multicenter study of patients with chronic kidney disease hospitalized for heart failure. The primary outcome was the difference in hemoglobin concentration. The secondary outcome was the difference in the prevalence of anemia.
Results: 229 patients were enrolled. Hemoglobin concentration was lower in patients with HFpEF compared to patients with HFrEF (11.1±1.8 g/dl vs 12.3±2.0 g/dl; p < 0.0001). . Presenting HFpEF was associated with a lower hemoglobin concentration (β1 = -0.90 g/dl; p = 0.001), after including the use of iron supplements, moderate to severe deterioration of glomerular filtration rate, sex and age. The prevalence of anemia was higher in patients with HFpEF compared to those with HFrEF (72.3% vs 59.8%; p = 0.0462). Belonging to the HFpEF group was not associated with anemia (OR = 1.77; p = 0.078), after including the same covariates. Exploratory, belonging to the HFpEF group was associated with moderate to severe anemia, after including the same covariates.
Conclusion: In patients with type IV cardiorenal syndrome, hemoglobin concentration is lower in patients hospitalized with HFpEF, possibly playing a role in the destabilization of these patients.
导论:因射血分数保留(HFpEF)心力衰竭住院的患者比因射血分数降低(HFpEF)心力衰竭住院的患者有更高的贫血患病率。然而,这种关系在慢性肾脏疾病患者中是否维持,形成心肾综合征iv型尚不清楚。方法:对因心力衰竭住院的慢性肾脏疾病患者进行横断面、多中心研究。主要结果是血红蛋白浓度的差异。次要结果是贫血患病率的差异。结果:229例患者入组。HFpEF患者的血红蛋白浓度低于HFrEF患者(11.1±1.8 g/dl vs 12.3±2.0 g/dl);P < 0.0001)。出现HFpEF与较低的血红蛋白浓度相关(β1 = -0.90 g/dl;P = 0.001),包括使用铁补充剂后,中度至重度肾小球滤过率恶化,性别和年龄。HFpEF患者的贫血患病率高于HFrEF患者(72.3% vs 59.8%;P = 0.0462)。属于HFpEF组与贫血无关(OR = 1.77;P = 0.078),包括相同的协变量后。探索性的,在纳入相同的协变量后,属于HFpEF组与中度至重度贫血相关。结论:在IV型心肾综合征患者中,HFpEF住院患者的血红蛋白浓度较低,可能在这些患者的不稳定中起作用。
{"title":"[Anemia and heart failure with preserved ejection fraction in adult patients with cardiorenal syndrome: a cross-sectional study]","authors":"Maria Teresa Politi, Gustavo Javier Daquarti, Damián Néstor Spagnuolo, Raúl Ferreyra, Mirta Diez, Guillermo Bortman","doi":"10.31053/1853.0605.v82.n1.44359","DOIUrl":"10.31053/1853.0605.v82.n1.44359","url":null,"abstract":"<p><strong>Introduction: </strong>Patients hospitalized for heart failure with preserved ejection fraction (HFpEF) have a higher prevalence of anemia than those hospitalized for heart failure with reduced ejection fraction (HFpEF). However, it is unknown if this relationship is maintained in patients with chronic kidney disease, forming cardiorenal syndrome type IV.</p><p><strong>Methods: </strong>Cross-sectional, multicenter study of patients with chronic kidney disease hospitalized for heart failure. The primary outcome was the difference in hemoglobin concentration. The secondary outcome was the difference in the prevalence of anemia.</p><p><strong>Results: </strong>229 patients were enrolled. Hemoglobin concentration was lower in patients with HFpEF compared to patients with HFrEF (11.1±1.8 g/dl vs 12.3±2.0 g/dl; p < 0.0001). . Presenting HFpEF was associated with a lower hemoglobin concentration (β1 = -0.90 g/dl; p = 0.001), after including the use of iron supplements, moderate to severe deterioration of glomerular filtration rate, sex and age. The prevalence of anemia was higher in patients with HFpEF compared to those with HFrEF (72.3% vs 59.8%; p = 0.0462). Belonging to the HFpEF group was not associated with anemia (OR = 1.77; p = 0.078), after including the same covariates. Exploratory, belonging to the HFpEF group was associated with moderate to severe anemia, after including the same covariates.</p><p><strong>Conclusion: </strong>In patients with type IV cardiorenal syndrome, hemoglobin concentration is lower in patients hospitalized with HFpEF, possibly playing a role in the destabilization of these patients.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"22-40"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objetives: Dermatofibrosarcoma protuberans is a sarcomatous neoplasm with low incidence. It exhibits slow growth; however, it has the capacity to involve deep tissues. Clinically, it can mimic benign lesions, presenting as thickened or atrophic plaques that slowly transform into protruding lesions. The treatment of choice is surgical excision, with Mohs micrographic surgery standing out for its advantages.
Clinical case: A 40-year-old male patient with dermatofibrosarcoma protuberans on the back underwent excision using the Mohs technique, with no tumor recurrence after two years of follow-up. Conclusion: It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate
Conclusion: It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate
{"title":"[Dermatofibrosarcoma protuberans treated with Mohs surgery]","authors":"Lía Salomé Abeledo, Carla Barbini, Gerardo Russier, Corina Busso","doi":"10.31053/1853.0605.v82.n1.45363","DOIUrl":"10.31053/1853.0605.v82.n1.45363","url":null,"abstract":"<p><strong>Objetives: </strong>Dermatofibrosarcoma protuberans is a sarcomatous neoplasm with low incidence. It exhibits slow growth; however, it has the capacity to involve deep tissues. Clinically, it can mimic benign lesions, presenting as thickened or atrophic plaques that slowly transform into protruding lesions. The treatment of choice is surgical excision, with Mohs micrographic surgery standing out for its advantages.</p><p><strong>Clinical case: </strong>A 40-year-old male patient with dermatofibrosarcoma protuberans on the back underwent excision using the Mohs technique, with no tumor recurrence after two years of follow-up. Conclusion: It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate</p><p><strong>Conclusion: </strong>It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"165-175"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-31DOI: 10.31053/1853.0605.v82.n1.44952
Raymundo Solís-Gómez, Itzel A Hernández-Dehesa, Aztlani Adan-Ruiz, Adrián F Sánchez-Cruz, Eduardo Argüelles-González
Introduction: Cryptococcal meningitis (CM) frequently associates immunocompromised patients, specifically in HIV infection, and it has high mortality. Neuro-ophthalmic manifestations are rare in patients with CM, especially internuclear ophthalmoplegia (INO) or wall-eyed bilateral internuclear ophthalmoplegia (WEBINO), most of them the result of secondary vasculitis.
Case report: A 53-year-old woman with chronic hepatic failure, had sudden drowsiness, diplopia, fever, and internuclear ophthalmoplegia. MRI showed generalized leptomeningeal enhancement plus infratentorial nodular enhancement type in the midbrain and left cerebellar hemisphere. An India ink test was positive for Cryptococcus neoformans.
Conclusion: Cryptococcal meningitis causes a wide spectrum of neurological manifestations, but neuro-ophthalmological signs are infrequent. Physicians should consider that these meningitis events are capable of generating symptoms due to intra-axial involvement of the Central Nervous System (CNS) due to vasculitis.
{"title":"Ophthalmoplegia as a Rare Initial Presentation of Cryptococcal Meningitis: A Case Report and Literature Review","authors":"Raymundo Solís-Gómez, Itzel A Hernández-Dehesa, Aztlani Adan-Ruiz, Adrián F Sánchez-Cruz, Eduardo Argüelles-González","doi":"10.31053/1853.0605.v82.n1.44952","DOIUrl":"10.31053/1853.0605.v82.n1.44952","url":null,"abstract":"<p><strong>Introduction: </strong>Cryptococcal meningitis (CM) frequently associates immunocompromised patients, specifically in HIV infection, and it has high mortality. Neuro-ophthalmic manifestations are rare in patients with CM, especially internuclear ophthalmoplegia (INO) or wall-eyed bilateral internuclear ophthalmoplegia (WEBINO), most of them the result of secondary vasculitis.</p><p><strong>Case report: </strong>A 53-year-old woman with chronic hepatic failure, had sudden drowsiness, diplopia, fever, and internuclear ophthalmoplegia. MRI showed generalized leptomeningeal enhancement plus infratentorial nodular enhancement type in the midbrain and left cerebellar hemisphere. An India ink test was positive for Cryptococcus neoformans.</p><p><strong>Conclusion: </strong>Cryptococcal meningitis causes a wide spectrum of neurological manifestations, but neuro-ophthalmological signs are infrequent. Physicians should consider that these meningitis events are capable of generating symptoms due to intra-axial involvement of the Central Nervous System (CNS) due to vasculitis.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"176-187"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Self-adjusting titration (APAP) at home is accepted to define therapeutic pressure (CPAPT). The APAP device report may be insufficient to ensure adequate therapeutic response in all patients. There is no consensus on the use of oximetry during APAP titration.
Objective: To evaluate the prevalence and magnitude of residual hypoxemia (RH) in titration with APAP not monitored at home and to identify related variables.
Materials and methods: Retrospective study based on APAP titrations with coupled oximetry, arterial blood gases and spirometry test. A T90 > 10% of the night was considered significant RH. Predictors of HR were identified by logistic regression (RL).
Results: 116 cases were included. 41% in the group with RH. These were older (66.7 vs. 59.6 years, p: 0.02), lower absolute FEV1 (2.17 vs. 2.57 liters, p: 0.06), lower absolute FVC (2.9 vs. 3.3 liters, p: 0.02) and lower basal PO2 (77.3 vs. 84.2 mmHg, p: 0.04). The titration period reached 3.6 ± 1 nights, average adherence of 374 ± 88.4 minutes/night; CPAPT (cm H2O): 9.4 ± 1.8, AHIr; 3.1 ± 3.2 ev/h and leaks (liters/min): 19.7 ± 11.2. Multiple logistic regression identified age > 66 years as a predictor of RH (OR 3.32, 95% CI 1.43 - 7.69, p: 0.005) and FEV1 < 1.76 liters (OR 3.29 – IC95% 1.27 – 8.53, p: 0.0139).
Conclusions: Incompletely corrected nocturnal oximetry was observed in a significant proportion of patients with APAP. Age over 66 years and absolute FEV1 < 1.76 liters were correlated with residual hypoxemia.
自我调节滴定(APAP)在家庭被接受来定义治疗压力(cpap)。APAP装置报告可能不足以确保所有患者都有足够的治疗反应。在APAP滴定过程中,氧饱和度的使用尚无共识。目的:评价未在家监测的APAP滴定中残留低氧血症(RH)的发生率和程度,并确定相关变量。材料与方法:回顾性研究基于APAP滴定与血氧仪、动脉血气和肺活量测定联合试验。A T90 >为夜间被认为是显著的RH的10%。通过logistic回归(RL)确定HR的预测因素。结果:共纳入116例。RH组有41%。这些患者年龄较大(66.7 vs. 59.6岁,p: 0.02),绝对FEV1较低(2.17 vs. 2.57升,p: 0.06),绝对FVC较低(2.9 vs. 3.3升,p: 0.02),基础PO2较低(77.3 vs. 84.2 mmHg, p: 0.04)。滴定周期为3.6±1晚,平均坚持时间为374±88.4分钟/晚;cpap (cm H2O): 9.4±1.8,AHIr;3.1±3.2 ev/h,泄漏量(升/分钟):19.7±11.2。多元logistic回归确定年龄bbb66岁是RH (OR 3.32, 95% CI 1.43 - 7.69, p: 0.005)和FEV1 < 1.76升(OR 3.29 - IC95% 1.27 - 8.53, p: 0.0139)的预测因子。结论:相当比例的APAP患者存在不完全校正的夜间血氧测定。年龄大于66岁,绝对FEV1 < 1.76 l与残余低氧血症相关。
{"title":"[Residual hypoxemia during titration with self-adjusting CPAP at home in patients without prior adaptation]","authors":"Julieta Franzoy, Magali Blanco, Glenda Ernst, Maria Belen Ginetti, Marcella Perri, Eduardo Borsini","doi":"10.31053/1853.0605.v82.n1.44671","DOIUrl":"10.31053/1853.0605.v82.n1.44671","url":null,"abstract":"<p><strong>Introduction: </strong>Self-adjusting titration (APAP) at home is accepted to define therapeutic pressure (CPAPT). The APAP device report may be insufficient to ensure adequate therapeutic response in all patients. There is no consensus on the use of oximetry during APAP titration.</p><p><strong>Objective: </strong>To evaluate the prevalence and magnitude of residual hypoxemia (RH) in titration with APAP not monitored at home and to identify related variables.</p><p><strong>Materials and methods: </strong>Retrospective study based on APAP titrations with coupled oximetry, arterial blood gases and spirometry test. A T90 > 10% of the night was considered significant RH. Predictors of HR were identified by logistic regression (RL).</p><p><strong>Results: </strong>116 cases were included. 41% in the group with RH. These were older (66.7 vs. 59.6 years, p: 0.02), lower absolute FEV1 (2.17 vs. 2.57 liters, p: 0.06), lower absolute FVC (2.9 vs. 3.3 liters, p: 0.02) and lower basal PO2 (77.3 vs. 84.2 mmHg, p: 0.04). The titration period reached 3.6 ± 1 nights, average adherence of 374 ± 88.4 minutes/night; CPAPT (cm H2O): 9.4 ± 1.8, AHIr; 3.1 ± 3.2 ev/h and leaks (liters/min): 19.7 ± 11.2. Multiple logistic regression identified age > 66 years as a predictor of RH (OR 3.32, 95% CI 1.43 - 7.69, p: 0.005) and FEV1 < 1.76 liters (OR 3.29 – IC95% 1.27 – 8.53, p: 0.0139).</p><p><strong>Conclusions: </strong>Incompletely corrected nocturnal oximetry was observed in a significant proportion of patients with APAP. Age over 66 years and absolute FEV1 < 1.76 liters were correlated with residual hypoxemia.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"61-77"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-31DOI: 10.31053/1853.0605.v82.n1.44424
Elizabeth Karen Videla, Pablo Ferrada, Jorge Miller, Eduardo Torres, Analía Álvarez, Javier Herrera, Bertha De la Torre
Introduction: hypoglycemia is a common and multifactorial clinical condition. A rare cause is that associated with non-islet cell tumors.
Objective: to report our experience on the management of severe hypoglycemia in a patient with solitary pleural fibrous tumor and his response to pasireotide.
Clinical case: 63-year-old patient with a history of glomerulonephritis, hypothyroidism, arterial hypertension and a one-year diagnosis of solitary pleural fibrous tumor. Referred to endocrinology due to hypoglycemia for 6 months. Acromegaloid features were confirmed. Laboratory: Hct 36%, Hb 11.9 g/dl, GB 3570/mm3 (Eo 2%, Ba2%, Bac 4%, NS 36%, Li 30%, Mo 14% metamyelocytes 1%, myelocytes 11%), platelets 120,000 /mm3, ESR 10 mm, CRP 9 mg/L, TP 114%, TTPK 25 sec, blood glucose 57 mg/dL, renal function, hepatogram and lipid profile without particularities. IGF-1 84 ng/ml (VR 57 - 188), C-peptide 0.10 ng/ml (VR 1.10 - 4.40), somatotropin 0.98 ng/ml (VR up to 2.5) and basal insulin 0.4 uU/ml (VR 2.6 - 24) . IFG-2 measurement is not available in Argentina. A chest CT showed a pleural tumor measuring 13 cm. Without possibilities of surgical resection and without response to chemotherapy. Treatment was started with infusion of 25% dextrose, dexamethasone, pasireotide with good response. The patient died due to an infectious complication.
Conclusion: pasireotide could be a therapeutic alternative in cases that are not candidates for surgery or refractory to other medical treatment.
{"title":"[Hypoglycemia in a patient with pleural solitary fibrous tumor and response to pasireotide]","authors":"Elizabeth Karen Videla, Pablo Ferrada, Jorge Miller, Eduardo Torres, Analía Álvarez, Javier Herrera, Bertha De la Torre","doi":"10.31053/1853.0605.v82.n1.44424","DOIUrl":"10.31053/1853.0605.v82.n1.44424","url":null,"abstract":"<p><strong>Introduction: </strong>hypoglycemia is a common and multifactorial clinical condition. A rare cause is that associated with non-islet cell tumors.</p><p><strong>Objective: </strong>to report our experience on the management of severe hypoglycemia in a patient with solitary pleural fibrous tumor and his response to pasireotide.</p><p><strong>Clinical case: </strong>63-year-old patient with a history of glomerulonephritis, hypothyroidism, arterial hypertension and a one-year diagnosis of solitary pleural fibrous tumor. Referred to endocrinology due to hypoglycemia for 6 months. Acromegaloid features were confirmed. Laboratory: Hct 36%, Hb 11.9 g/dl, GB 3570/mm3 (Eo 2%, Ba2%, Bac 4%, NS 36%, Li 30%, Mo 14% metamyelocytes 1%, myelocytes 11%), platelets 120,000 /mm3, ESR 10 mm, CRP 9 mg/L, TP 114%, TTPK 25 sec, blood glucose 57 mg/dL, renal function, hepatogram and lipid profile without particularities. IGF-1 84 ng/ml (VR 57 - 188), C-peptide 0.10 ng/ml (VR 1.10 - 4.40), somatotropin 0.98 ng/ml (VR up to 2.5) and basal insulin 0.4 uU/ml (VR 2.6 - 24) . IFG-2 measurement is not available in Argentina. A chest CT showed a pleural tumor measuring 13 cm. Without possibilities of surgical resection and without response to chemotherapy. Treatment was started with infusion of 25% dextrose, dexamethasone, pasireotide with good response. The patient died due to an infectious complication.</p><p><strong>Conclusion: </strong>pasireotide could be a therapeutic alternative in cases that are not candidates for surgery or refractory to other medical treatment.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"127-139"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057705/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-31DOI: 10.31053/1853.0605.v82.n1.45328
Judith Frydman, Mara Inés López
Introduction: a significant number of children suffer cognitive, physical, mental and social limitations as a result of critical illnesses and their subsequent treatment. Pollack et al. developed the functional status scale with the purpose of measuring the change in functional status during hospitalization.
Objectives: evaluate the acquired morbidity upon discharge from the Pediatric Intensive Care Unit (PICU). Specific objectives: compare mortality and acquired morbidity rates, analyze changes in functional status categories, identify the most affected domains, describe relationships between domain affection and admission diagnosis, between domain affection and age group, between morbidity and days in invasive mechanical ventilation (IMV), non-invasive ventilation and high-flow oxygen therapy.
Methodology: observational, descriptive, prospective and longitudinal study. Patients between 1 and 180 months of age requiring ventilatory support for at least 48 hours, between February 2021 and February 2024, were included.
Results: 90.9% survived, and of these, 26.9% developed acquired morbidity. The 42% of patients changed their functional status at least one point. The most affected domains were motor and feeding. Those who died had fewer days of IMV and hospitalization.
Conclusion: The incidence of acquired morbidity was higher than mortality in the analyzed period. Children who developed morbidity remained hospitalized for a longer period of time and had greater requirements and days of IMV. Increased survival makes mortality an insufficient outcome metric. More studies with longer follow-up are needed.
{"title":"[Incidence of acquired morbidity and its impact on patients in a pediatric intensive care unit based on the functional status scale]","authors":"Judith Frydman, Mara Inés López","doi":"10.31053/1853.0605.v82.n1.45328","DOIUrl":"10.31053/1853.0605.v82.n1.45328","url":null,"abstract":"<p><strong>Introduction: </strong>a significant number of children suffer cognitive, physical, mental and social limitations as a result of critical illnesses and their subsequent treatment. Pollack et al. developed the functional status scale with the purpose of measuring the change in functional status during hospitalization.</p><p><strong>Objectives: </strong>evaluate the acquired morbidity upon discharge from the Pediatric Intensive Care Unit (PICU). Specific objectives: compare mortality and acquired morbidity rates, analyze changes in functional status categories, identify the most affected domains, describe relationships between domain affection and admission diagnosis, between domain affection and age group, between morbidity and days in invasive mechanical ventilation (IMV), non-invasive ventilation and high-flow oxygen therapy.</p><p><strong>Methodology: </strong>observational, descriptive, prospective and longitudinal study. Patients between 1 and 180 months of age requiring ventilatory support for at least 48 hours, between February 2021 and February 2024, were included.</p><p><strong>Results: </strong>90.9% survived, and of these, 26.9% developed acquired morbidity. The 42% of patients changed their functional status at least one point. The most affected domains were motor and feeding. Those who died had fewer days of IMV and hospitalization.</p><p><strong>Conclusion: </strong>The incidence of acquired morbidity was higher than mortality in the analyzed period. Children who developed morbidity remained hospitalized for a longer period of time and had greater requirements and days of IMV. Increased survival makes mortality an insufficient outcome metric. More studies with longer follow-up are needed.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"41-60"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-31DOI: 10.31053/1853.0605.v82.n1.45349
Anyhely Yhoan Escudero Quispe, José Luis Vivanco Osorio
This study finds a gradual increase in women's age at first pregnancy, a situation that has been associated with an increased risk of adverse maternal and postpartum events. While in the mid-1970s there were 1.7 per thousand pregnant nulliparous women between 35 and 39 years old, in 2012 this figure increased to 11 per thousand pregnant women, a six-fold increase. The global prevalence of pregnant women over 35 years of age is estimated at 12.3%. Maternal and perinatal characteristics and outcomes of nulliparous women aged 40 years and older are described and compared with characteristics of nulliparous women younger than 40 years. During the time of said study, approximately 4095 nulliparous female patients who met the inclusion criteria were treated; however, a limitation was found because it was a closed population treated in a highly complex tertiary hospital, the majority with high level of schooling and middle class socioeconomic level. In conclusion, older women constitute a high-risk population whose management and follow-up would require a different approach aimed at improving maternal and postpartum outcomes.
{"title":"[Advanced maternal age as a risk factor for adverse perinatal outcomes]","authors":"Anyhely Yhoan Escudero Quispe, José Luis Vivanco Osorio","doi":"10.31053/1853.0605.v82.n1.45349","DOIUrl":"10.31053/1853.0605.v82.n1.45349","url":null,"abstract":"<p><p>This study finds a gradual increase in women's age at first pregnancy, a situation that has been associated with an increased risk of adverse maternal and postpartum events. While in the mid-1970s there were 1.7 per thousand pregnant nulliparous women between 35 and 39 years old, in 2012 this figure increased to 11 per thousand pregnant women, a six-fold increase. The global prevalence of pregnant women over 35 years of age is estimated at 12.3%. Maternal and perinatal characteristics and outcomes of nulliparous women aged 40 years and older are described and compared with characteristics of nulliparous women younger than 40 years. During the time of said study, approximately 4095 nulliparous female patients who met the inclusion criteria were treated; however, a limitation was found because it was a closed population treated in a highly complex tertiary hospital, the majority with high level of schooling and middle class socioeconomic level. In conclusion, older women constitute a high-risk population whose management and follow-up would require a different approach aimed at improving maternal and postpartum outcomes.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"223-230"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current beauty standards have influenced individuals to seek an aesthetically "ideal" nose, leading them to pursue non-surgical strategies like rhinomodeling using hyaluronic acid or surgical approaches such as rhinoplasty. The use of hyaluronic acid in the nose can complicate its manipulation in the event of subsequent surgical intervention and carries various risks if performed by unqualified personnel.
{"title":"[ Accumulation of hyaluronic acid in rhinoseptoplasty: intraoperative finding]","authors":"Sebastián Abad-Cuenca, Xavier Eduardo Abad-González","doi":"10.31053/1853.0605.v82.n1.45169","DOIUrl":"10.31053/1853.0605.v82.n1.45169","url":null,"abstract":"<p><p>Current beauty standards have influenced individuals to seek an aesthetically \"ideal\" nose, leading them to pursue non-surgical strategies like rhinomodeling using hyaluronic acid or surgical approaches such as rhinoplasty. The use of hyaluronic acid in the nose can complicate its manipulation in the event of subsequent surgical intervention and carries various risks if performed by unqualified personnel.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"215-222"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-31DOI: 10.31053/1853.0605.v82.n1.45253
Marcelo A Rada, Paula Edit Cuffaro, María Celeste Szydlowicz, Verónica Andrea Peuchot, Margarita Susana Morales, Jorge Javier Janson, Ruben Micali, José Alfie, Carlos Rodolfo Galarza
Objective: To compare the new cardiograph ZLogic for non-invasive measurements of Stroke volume (SV) and Cardiac output (CO) against the Minnesota cardiograph.
Methods: 86 subjects from both genders, 18-80 years old, hypertensive and healthy volunteers were included. Three hemodynamic measurements performed with each device, in an alternate fashion, using the Bland-Altman method to determine the level of agreement. Percentage error was calculated for interchangeability of both methods.
Results: Mean SV was 86.71±27.35 mL and mean CO 5.42±1.74 L/min. There was a strong correlation between measures of SV and CO obtained with both devices (r=0.99, p<0.001). Mean difference (MD) for SV was 0.65±3.08 mL (CI95%: -0.01-1.31) and 95% limits of agreement −5.39 to +6.69 mL. MD for CO was 0.05±0.17 L/min (CI95%: 0.01-0.09) and the 95% limits of agreement −0.28 to +0.38 L/min.
Conclusion: ZLogic and Minnesota cardiographs provided equivalent SV and CO values in ambulatory hypertensive patients.
{"title":"[Validation of a new impedance cardiography device for noninvasive hemodynamic measurement in outpatient hypertensive patients]","authors":"Marcelo A Rada, Paula Edit Cuffaro, María Celeste Szydlowicz, Verónica Andrea Peuchot, Margarita Susana Morales, Jorge Javier Janson, Ruben Micali, José Alfie, Carlos Rodolfo Galarza","doi":"10.31053/1853.0605.v82.n1.45253","DOIUrl":"10.31053/1853.0605.v82.n1.45253","url":null,"abstract":"<p><strong>Objective: </strong>To compare the new cardiograph ZLogic for non-invasive measurements of Stroke volume (SV) and Cardiac output (CO) against the Minnesota cardiograph.</p><p><strong>Methods: </strong>86 subjects from both genders, 18-80 years old, hypertensive and healthy volunteers were included. Three hemodynamic measurements performed with each device, in an alternate fashion, using the Bland-Altman method to determine the level of agreement. Percentage error was calculated for interchangeability of both methods.</p><p><strong>Results: </strong>Mean SV was 86.71±27.35 mL and mean CO 5.42±1.74 L/min. There was a strong correlation between measures of SV and CO obtained with both devices (r=0.99, p<0.001). Mean difference (MD) for SV was 0.65±3.08 mL (CI95%: -0.01-1.31) and 95% limits of agreement −5.39 to +6.69 mL. MD for CO was 0.05±0.17 L/min (CI95%: 0.01-0.09) and the 95% limits of agreement −0.28 to +0.38 L/min.</p><p><strong>Conclusion: </strong>ZLogic and Minnesota cardiographs provided equivalent SV and CO values in ambulatory hypertensive patients.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"95-109"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-31DOI: 10.31053/1853.0605.v82.n1.42871
Maria Elisa Rivas, Melania Ron, Fernando Martín Salierno, María Soledad Broggi, Lucas Bonamico
Introduction: After suffering brain damage with altered consciousness, clinically stable patients are referred to rehabilitation programs. The objective of this study is to describe the results of a transdisciplinary multisensory stimulation program in adults with altered consciousness admitted to a rehabilitation center in Argentina between 2006 and 2022.
Methodology: A retrospective case series study was conducted that included 178 patients who completed the multisensory stimulation program. Consciousness was assessed with the Coma Recovery Scale – Revised (CRS-R), functional outcome with the Functional Independence Measure (FIM), and disability with the Disability Rating Scale (DRS).
Results: The majority of patients (68%) were men with a diagnosis of unresponsive wakefulness syndrome (RSVS). The median time of injury to admission was 77 days, and the average length of stay was 127 days. The median CRS-R at admission was 6 and 10 at discharge (p = 0.01). The highest percentage (61.8%) of emergence was in traumatic injuries. Patients who emerged showed a significant functional improvement, with a median FIM = 44 and DRS = 11. The stay was significantly shorter in those who emerged (70 vs. 163 days; p = 0.001).
Conclusion: These results highlight the benefit of a transdisciplinary multisensory stimulation program to improve diagnostic evaluation and promote recovery of consciousness in patients with severe brain injury.
{"title":"[Outcomes of a Transdisciplinary Rehabilitation Program for Patients with Consciousness Disorders (2006-2022, Argentina)]","authors":"Maria Elisa Rivas, Melania Ron, Fernando Martín Salierno, María Soledad Broggi, Lucas Bonamico","doi":"10.31053/1853.0605.v82.n1.42871","DOIUrl":"10.31053/1853.0605.v82.n1.42871","url":null,"abstract":"<p><strong>Introduction: </strong>After suffering brain damage with altered consciousness, clinically stable patients are referred to rehabilitation programs. The objective of this study is to describe the results of a transdisciplinary multisensory stimulation program in adults with altered consciousness admitted to a rehabilitation center in Argentina between 2006 and 2022.</p><p><strong>Methodology: </strong>A retrospective case series study was conducted that included 178 patients who completed the multisensory stimulation program. Consciousness was assessed with the Coma Recovery Scale – Revised (CRS-R), functional outcome with the Functional Independence Measure (FIM), and disability with the Disability Rating Scale (DRS).</p><p><strong>Results: </strong>The majority of patients (68%) were men with a diagnosis of unresponsive wakefulness syndrome (RSVS). The median time of injury to admission was 77 days, and the average length of stay was 127 days. The median CRS-R at admission was 6 and 10 at discharge (p = 0.01). The highest percentage (61.8%) of emergence was in traumatic injuries. Patients who emerged showed a significant functional improvement, with a median FIM = 44 and DRS = 11. The stay was significantly shorter in those who emerged (70 vs. 163 days; p = 0.001).</p><p><strong>Conclusion: </strong>These results highlight the benefit of a transdisciplinary multisensory stimulation program to improve diagnostic evaluation and promote recovery of consciousness in patients with severe brain injury.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"6-21"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}